Reach Neuro, Inc.

Reach Neuro, Inc. is a medical device company based in Pittsburgh, founded in 2021. The company specializes in innovative treatments for chronic stroke patients, particularly those with upper-limb paralysis. Its primary product is the Avantis spinal cord stimulation platform, an implantable neuromodulator system that uses electrodes to deliver targeted electrical impulses to the spinal cord. This technology aims to restore voluntary motor function in individuals with long-term motor deficits caused by stroke. The Avantis system stimulates intact neural circuits to improve motor control of the shoulder, arm, and hand, offering hope to nearly 50% of stroke survivors who experience permanent upper limb impairment. Reach Neuro's solutions include neurostimulation therapy designed to work with the nervous system and clinical development efforts that have earned the FDA's breakthrough device designation for expedited review. The company serves chronic stroke patients, healthcare providers, rehabilitation centers, and clinical researchers focused on advancing neurostimulation therapies.

• Employees 5
• Total Funding $200000